-
Janney: 4 Reasons Why Selecta Biosciences Is 'Significantly Undervalued'
Wednesday, June 27, 2018 - 12:26pm | 436Selecta Biosciences Inc (NASDAQ: SELB) shares plummeted in November 2017 from the $20 level and have yet to recover. The stock should not only recoup all of its losses, but trade at new all-time highs, according to Janney. The Analyst Janney's Yun Zhong initiated coverage of Selecta...